🔎 Trials Near Me

Gara Jalqabaatti › Saree (Gosoota Hunda) › North Carolina › Charlotte

Qorannoo klinikaalii Saree (Gosoota Hunda) Charlotte, NC keessatti

Qorannoo 27 Saree (Gosoota Hunda) f Charlotte fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Registry Study for Radiation Therapy Outcomes

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Atrium Health Levine Cancer Proton & Advanced Radiation Center, Charlotte
Umuriin hundi · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT01255748

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Namoota walitti qabaa jiraSadarkaa 2/3
  • Levine Cancer Institute, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06989437

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • Levine Cancer Institute, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06150157

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Atrium Health's Levine Cancer Institute, Charlotte
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Namoota walitti qabaa jiraSadarkaa 2/3
  • Levine Cancer Institute, Charlotte
Umuriin hundi · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT03435796

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Atrium Health Levine Cancer Institute /ID# 271510, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06953960

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT05123482

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Oncology Specialists of Charlotte, Charlotte
  • Southern Oncology Specialists, Huntersville · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07169851

Comprehensive Care for AYA: Needs Assessment Survey

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Atrium Health Levine Cancer, Charlotte
Umuriin 15 fi ol · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07196241

A Study of ARC-02 in B-cell NHL

Namoota walitti qabaa jiraSadarkaa 1
  • Levine Cancer Institute, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07691606

Project: Every Child for Younger Patients With Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • Novant Health Presbyterian Medical Center, Charlotte
Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT02402244

Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Atrium Health Levine Cancer, Charlotte
Umuriin 50 fi ol · Dubartoota · Haaromfame 30-Ado-2026 · NCT07046936

A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy

Namoota walitti qabaa jiraSadarkaa 2
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Charlotte
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT06866964

Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Levine Childrens Hospital Pediatric Cancer and Blood Disorders, Charlotte
  • Levine Cancer Institute, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT06634381

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

Namoota walitti qabaa jiraSadarkaa 2
  • Levine Cancer Institute, Charlotte
Umuriin 2 hanga 21 · Saalaa hunda · Haaromfame 23-Ado-2026 · NCT04948619

LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients

Namoota walitti qabaa jira
  • Levine Children's Hospital, Charlotte
Umuriin 2 hanga 25 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT05058508

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

Namoota walitti qabaa jiraSadarkaa 1/2
  • Atrium Health Levine Cancer Institute /ID# 276193, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ado-2026 · NCT06892522

A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial

Namoota walitti qabaa jira
  • Atrium Health Levine Cancer, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT07119489

Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway

Namoota walitti qabaa jira
  • Levine Cancer Institute, Charlotte
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT07175376

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Carolina BioOncology Institute, Huntersville · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT06993844

Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 2
  • Levine Cancer Institute, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Wax-2026 · NCT05145400

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Namoota walitti qabaa jiraSadarkaa 2
  • Novant Health Presbyterian Medical Center /ID# 230201, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Gur-2026 · NCT04895436

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Carolina BioOncology Institute, Huntersville · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ama-2026 · NCT07317505

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Levine Cancer Institute, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Sad-2025 · NCT05997017

Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Carolina BioOncology Institute, Huntersville · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Ful-2025 · NCT05055609

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Levine Cancer Institute, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2025 · NCT05768269

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Carolina Blood and Cancer Care Associates, Rock Hill · Miili 23 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Bit-2025 · NCT06635954

Qorannoo Saree (Gosoota Hunda) magaalota biroo keessatti

Qorannoo biroo Charlotte keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.